Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-market Interventional Cohort Study Evaluating the Clinical Efficacy of the Osia 2 System in the US Market.

NCT04320407 is registered in ClinicalTrials.gov with Cochlear as lead sponsor.

NCT NCT04320407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04320407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-market Interventional Cohort Study Evaluating the Clinical Efficacy of the Osia 2 System in the US Market.
Lead sponsor
Cochlear
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2020
Completion date
December 28, 2021
Enrollment
20 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

conductive hearing loss, mixed hearing loss